Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in <i>BRCA1</i> or <i>BRCA2</i>

Our findings suggest there is no significant increase in the risk of breast cancer in BRCA carriers with the use of MHT and that E alone might be protective.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-12-13
DOI
https://doi.org/10.1093/jnci/djaf363
Citations
1
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2

Nadine Tung, Fergus J. Couch, Teresa Ramón y Cajal, Kelly Metcalfe et al.
1 citations
JNCI Journal of the National Cancer Institute
BRCA gene mutations in cancer
1.82
article

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2

Nadine Tung, Fergus J. Couch, Teresa Ramón y Cajal, Kelly Metcalfe, Jan Lubiński, Tomasz Huzarski, William D. Foulkes, Louise Bordeleau, Tuya Pal, Amber M. Aeilts, Dana Zakalik, Marta Seca, Raymond H. Kim, Robert Fruscio, Andrea Eisen, Beth Y. Karlan, Cezary Cybulski, Joanne Kotsopoulos, Pål Møller, Christian F. Singer, Jacek Gronwald, Steven A Narod, Susan L. Neuhausen, Ping Sun, Olufunmilayo Olopade
article en
1 citations

Abstract

Our findings suggest there is no significant increase in the risk of breast cancer in BRCA carriers with the use of MHT and that E alone might be protective.

JNCI Journal of the National Cancer Institute
Oslo University Hospital (NO), Beth Israel Deaconess Medical Center (US), Sunnybrook Health Science Centre (CA), University Health Network (CA), Mayo Clinic (US), 3M (United States) (US), Johns Hopkins University (US), University of California, Los Angeles (US), Oakland University (US), University of Toronto (CA), Beaumont Health (US), Juravinski Cancer Centre (CA), Norwegian Cancer Society (NO), McGill University Health Centre (CA), Hospital de Sant Pau (ES), Women's College Hospital (CA), Princess Margaret Cancer Centre (CA), The Ohio State University Wexner Medical Center (US), University of Chicago (US), Comprehensive Cancer Center Vienna (AT), City of Hope (US), Azienda Ospedaliera San Gerardo (IT), Mayo Clinic in Arizona (US), Public Health Ontario (CA), Cancer Genetics (United States) (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT), International Hereditary Cancer Center (PL), Beckman Research Institute, McGill University (CA), The Ohio State University (US), University of Milano-Bicocca (IT), Medical University of Vienna (AT), Vanderbilt University Medical Center (US), McMaster University (CA)
Openalex Percentile: Top 11%
BRCA gene mutations in cancer
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.